185 related articles for article (PubMed ID: 22389453)
1. Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth.
Kawabata A; Baoum A; Ohta N; Jacquez S; Seo GM; Berkland C; Tamura M
Cancer Res; 2012 Apr; 72(8):2057-67. PubMed ID: 22389453
[TBL] [Abstract][Full Text] [Related]
2. Combined Local Pulmonary and Systemic Delivery of AT2R Gene by Modified TAT Peptide Nanoparticles Attenuates Both Murine and Human Lung Carcinoma Xenografts in Mice.
Ishiguro S; Alhakamy NA; Uppalapati D; Delzeit J; Berkland CJ; Tamura M
J Pharm Sci; 2017 Jan; 106(1):385-394. PubMed ID: 27769520
[TBL] [Abstract][Full Text] [Related]
3. AT2R Gene Delivered by Condensed Polylysine Complexes Attenuates Lewis Lung Carcinoma after Intravenous Injection or Intratracheal Spray.
Alhakamy NA; Ishiguro S; Uppalapati D; Berkland CJ; Tamura M
Mol Cancer Ther; 2016 Jan; 15(1):209-18. PubMed ID: 26637367
[TBL] [Abstract][Full Text] [Related]
4. Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.
Ishiguro S; Yoshimura K; Tsunedomi R; Oka M; Takao S; Inui M; Kawabata A; Wall T; Magafa V; Cordopatis P; Tzakos AG; Tamura M
Cancer Biol Ther; 2015; 16(2):307-16. PubMed ID: 25756513
[TBL] [Abstract][Full Text] [Related]
5. Cell penetrating peptide of sodium-iodide symporter effect on the I-131 radiotherapy on thyroid cancer.
Fan YX; Liang ZX; Liu QZ; Xiao H; Li KB; Wu JZ
Exp Ther Med; 2017 Mar; 13(3):989-994. PubMed ID: 28450931
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells.
Pickel L; Matsuzuka T; Doi C; Ayuzawa R; Maurya DK; Xie SX; Berkland C; Tamura M
Cancer Biol Ther; 2010 Feb; 9(4):277-85. PubMed ID: 20026904
[TBL] [Abstract][Full Text] [Related]
7. Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis.
Clere N; Corre I; Faure S; Guihot AL; Vessières E; Chalopin M; Morel A; Coqueret O; Hein L; Delneste Y; Paris F; Henrion D
Int J Cancer; 2010 Nov; 127(10):2279-91. PubMed ID: 20143398
[TBL] [Abstract][Full Text] [Related]
8. GRP75-driven, cell-cycle-dependent macropinocytosis of Tat/pDNA-Ca
Su L; Sun Z; Qi F; Su H; Qian L; Li J; Zuo L; Huang J; Yu Z; Li J; Chen Z; Zhang S
J Nanobiotechnology; 2022 Jul; 20(1):340. PubMed ID: 35858873
[TBL] [Abstract][Full Text] [Related]
9. A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia in mice.
Liu CH; Chern GJ; Hsu FF; Huang KW; Sung YC; Huang HC; Qiu JT; Wang SK; Lin CC; Wu CH; Wu HC; Liu JY; Chen Y
Hepatology; 2018 Mar; 67(3):899-913. PubMed ID: 28885731
[TBL] [Abstract][Full Text] [Related]
10. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies.
Kaul G; Amiji M
Pharm Res; 2005 Jun; 22(6):951-61. PubMed ID: 15948039
[TBL] [Abstract][Full Text] [Related]
11. Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.
Wang Y; Su HH; Yang Y; Hu Y; Zhang L; Blancafort P; Huang L
Mol Ther; 2013 Feb; 21(2):358-67. PubMed ID: 23229091
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
Zhang B; Zhang Y; Yu D
Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442
[TBL] [Abstract][Full Text] [Related]
13. AAV-mediated gene transfer of human pigment epithelium-derived factor inhibits Lewis lung carcinoma growth in mice.
He SS; Shi HS; Yin T; Li YX; Luo ST; Wu QJ; Lu L; Wei YQ; Yang L
Oncol Rep; 2012 Apr; 27(4):1142-8. PubMed ID: 22218393
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection.
Hu YL; Huang B; Zhang TY; Miao PH; Tang GP; Tabata Y; Gao JQ
Mol Pharm; 2012 Sep; 9(9):2698-709. PubMed ID: 22862421
[TBL] [Abstract][Full Text] [Related]
15. In vivo gene delivery with L-tyrosine polyphosphate nanoparticles.
Ditto AJ; Reho JJ; Shah KN; Smolen JA; Holda JH; Ramirez RJ; Yun YH
Mol Pharm; 2013 May; 10(5):1836-44. PubMed ID: 23510151
[TBL] [Abstract][Full Text] [Related]
16. A TRAIL-Delivered Lipoprotein-Bioinspired Nanovector Engineering Stem Cell-Based Platform for Inhibition of Lung Metastasis of Melanoma.
Chen K; Cao X; Li M; Su Y; Li H; Xie M; Zhang Z; Gao H; Xu X; Han Y; Zhou J; Wang W
Theranostics; 2019; 9(10):2984-2998. PubMed ID: 31244937
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma.
Wang K; Kievit FM; Jeon M; Silber JR; Ellenbogen RG; Zhang M
Adv Healthc Mater; 2015 Dec; 4(17):2719-26. PubMed ID: 26498165
[TBL] [Abstract][Full Text] [Related]
18. Development of non-viral vector for cancer gene therapy.
Hattori Y
Yakugaku Zasshi; 2010 Jul; 130(7):917-23. PubMed ID: 20606371
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
Xiao W; Chen X; Yang L; Mao Y; Wei Y; Chen L
Int J Pharm; 2010 Jun; 393(1-2):119-26. PubMed ID: 20416367
[TBL] [Abstract][Full Text] [Related]
20. Intratracheal Administration of Hyaluronan-Cisplatin Conjugate Nanoparticles Significantly Attenuates Lung Cancer Growth in Mice.
Ishiguro S; Cai S; Uppalapati D; Turner K; Zhang T; Forrest WC; Forrest ML; Tamura M
Pharm Res; 2016 Oct; 33(10):2517-29. PubMed ID: 27335023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
